Related Experiment Videos
[Botulinum toxin in oromaxillofacial surgery]
1Klinik für Mund-, Kiefer- und Gesichtschirurgie, Klinikum der Philipps-Universität Marburg. umstadt@mailer.uni-marburg.de
Summary
Botulinum toxin A offers a minimally invasive approach for treating jaw and facial muscle disorders, providing short-term correction with few side effects. This method addresses various functional and aesthetic impairments, improving patient quality of life.
Area of Science:
- Craniomaxillofacial surgery
- Neuromuscular disorders
- Aesthetic medicine
Context:
- The jaw and facial muscular system exhibits complex dynamics, with abnormalities leading to significant aesthetic and functional impairments.
- Current surgical treatments for muscular imbalances are often irreversible and can damage nerve and muscle structures.
- Botulinum toxin A presents a minimally invasive alternative for managing these conditions.
Purpose:
- To survey established and novel applications of botulinum toxin A in craniomaxillofacial surgery.
- To highlight the use of botulinum toxin A for treating masticatory and mimic muscle dysfunctions.
- To explore its role in managing salivary gland disorders and aesthetic corrections.
Summary:
- Botulinum toxin A provides short-term correction of muscular activities with a favorable side effect profile when applied precisely.
- Applications include treating masticatory and mimic muscle imbalances, hypersalivation, Frey's syndrome, and aesthetic facial concerns.
- It serves as an alternative to surgery for temporomandibular joint (TMJ) dislocation and for preventing relapse after mandibular advancement.
Impact:
- Offers a less invasive treatment option compared to traditional surgery for various craniomaxillofacial conditions.
- Improves patient outcomes by addressing both functional deficits and aesthetic concerns associated with muscular disorders.
- Potential to reduce chronic pain and psychopathological conditions linked to persistent facial muscle dysfunction.